Drug regulator approves emergency use of remdesivir to treat
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
India's government has approved Gilead Sciences Inc's antiviral drug remdesivir for emergency use in treating Covid-19 patients.

Remdesivir is the first drug to show improvement in Covid-19 patients in formal clinical trials. It was granted emergency use authorization by the US Food and Drug Administration last month and has received approval by Japanese health regulators.

"(Remdesivir) approved on June 1 under emergency use with a condition for five dose administration," the Drugs Controller General of India said in an email statement.

Gilead Sciences on June 1 reported that remdesivir showed modest benefit in patients with moderate Covid-19 given a five-day course, while those who received it for 10 days in the study did not fare as well.

Source: https://timesofindia.indiatimes.com/india/india-approves-emergency-use-of-remdesivir-to-treat-covid-19-patients/articleshow/76152949.cms
Dr. T●●●●z H●●●●●●i and 14 others like this8 shares
Like
Comment
Share